Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (7)
  • 2025 (17)
  • 2024 (21)
  • 2023 (47)
  • 2022 (65)
  • 2021 (56)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (1312)
  • Synthetic drugs (446)
  • Guns/Weapons (337)
  • OCDETF/Task Force (207)
  • Seizures (Drugs/Property) (204)
  • Guilty Plea (186)
  • Arrests/Convictions - Major (158)
  • Fake Pills (147)
  • Task Forces/Task Force Officers (120)
  • Overdose (108)
  • Prescription Drugs (101)
  • Major Law Enforcement Operation (100)
  • Diversion Division (70)
  • Money Laundering (55)
  • Outreach/Drug Prevention (54)
  • Gangs (51)
  • Take Back Day (49)
  • HIDTA (32)
  • Fentanyl Free America (31)
  • Counterfeit Pills (30)
  • Press Conferences (26)
  • Public and Media Affairs - also see Congressional Affairs (25)
  • Fentanyl Awareness (21)
  • Prevention/Education - DEA websites GSAD, JTT etc (20)
  • Narcoterrorism (17)
  • Extraditions (14)
  • One Pill Can Kill (12)
  • Asset Forfeiture (8)
  • Dark Web- Internet Trafficking (7)
  • International/Foreign Operations (7)
  • Campaigns (6)
  • Cartel (6)
  • Other (5)
  • Critical Incident (4)
  • Intergovernmental Affairs (3)
  • Museum and Visitors Center (3)
  • Red Ribbon (3)
  • Congressional Affairs (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (72)

Drug Name

  • Opioids (14)
  • Oxycodone (13)
  • Fentanyl (10)
  • Hydromorphone (9)
  • Benzodiazepines (2)
  • Morphine (2)
  • Synthetic Opioids (2)
  • Amphetamines (1)
  • Methamphetamine (1)
  • Steroids (1)

Field Division

  • Washington, DC (12)
  • St. Louis (11)
  • Miami (7)
  • Chicago (6)
  • New Jersey (6)
  • El Paso (5)
  • New York (5)
  • Houston (4)
  • New England (4)
  • Seattle (3)
  • Louisville (2)
  • San Diego (2)
  • Atlanta (1)
  • Omaha (1)
  • Phoenix (1)
  • San Francisco (1)
  • Sede (1)
Clear All Results
72 Results - Showing 1 to 10
PRESS RELEASE

DEA issues Immediate Suspension Orders to a Tennessee pharmacy over Controlled Substances Act violations

LOUISVILLE, Ky. – Earlier today, the U.S. Drug Enforcement Administration issued an Immediate Suspension Orders (ISO) to A + Pharmacy, a retail drug store located in Chattanooga, Tennessee. An ISO is an emergency administrative action that immediately suspends a DEA registrant's authority to handle controlled substances, due to imminent danger...
PRESS RELEASE

Pharmacist Indicted for Stealing Drugs from Employer

WICHITA, KAN. – A federal grand jury in Wichita returned an indictment charging a Kansas pharmacist for allegedly taking prescription drugs from a former employer for his personal use. According to court documents, Logan Marshall Abbott, 33, of Maize was indicted on one count of acquiring and obtaining a controlled...
PRESS RELEASE

Sutter Facilities Agree to Pay $3.2 Million to Resolve Alleged Controlled Substances Act Violations

SACRAMENTO, Calif. — Sutter Medical Center, Sacramento, and Sutter Fairfield Surgery Center have agreed to pay $3.2 million to resolve allegations that they failed to effectively guard against theft and diversion of controlled substances, U.S. Attorney Eric Grant and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced...
PRESS RELEASE

DEA Issues Immediate Suspension Order to Kentucky Pharmaceutical Distributor Over Controlled Substances Act Violations

LOUISVILLE, Ky. – Earlier today, the U.S. Drug Enforcement Administration issued an Immediate Suspension Order (ISO) to Richie Pharmacal, a pharmaceutical distributor in Glasgow, Kentucky. An ISO is an emergency administrative action that immediately suspends a DEA registrant's authority to handle controlled substances, due to imminent danger to public health...
PRESS RELEASE

Former Anesthesiology Resident Who Worked at Seattle Children's, UW Medicine, and Harborview Medical Center, Sentenced for Stealing and Using Narcotic Pain Medicine While on Duty

SEATTLE – A 36-year-old former anesthesiology resident at Seattle Children’s Hospital and Harborview and University of Washington Medical Centers was sentenced today in U.S. District Court in Seattle to one year of supervised release including 200 hours of community service for diverting narcotic pain medication to his own use while...
PRESS RELEASE

El Paso Doctor Enters $200,000 Settlement Following State and Federal Fraud Allegations

EL PASO, Texas – Dr. Brian August, located in El Paso, has agreed to pay $200,000 to resolve allegations that he violated the Controlled Substances Act, the False Claims Act, and the Texas Health Care Program Fraud Prevention Act. The allegations involved the issuance of 255 controlled substance prescriptions to...
PRESS RELEASE

Portland Veterinarian Sentenced for Diverting Controlled Substances for Personal Use

PORTLAND, Ore. — Dr. Brenda Brown-Carlson, a Portland veterinarian, was sentenced to 60 months of supervised probation on January 13, 2026, in Multnomah County Circuit Court as part of a plea agreement. Brown-Carlson admitted to diverting controlled substances for her personal use and replacing them with saline, impacting the treatment...
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
PRESS RELEASE

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants

WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster